Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Nardilysin controls intestinal tumorigenesis through HDAC1/p53–dependent transcriptional regulation
Keitaro Kanda, Jiro Sakamoto, Yoshihide Matsumoto, Kozo Ikuta, Norihiro Goto, Yusuke Morita, Mikiko Ohno, Kiyoto Nishi, Koji Eto, Yuto Kimura, Yuki Nakanishi, Kanako Ikegami, Takaaki Yoshikawa, Akihisa Fukuda, Kenji Kawada, Yoshiharu Sakai, Akihiro Ito, Minoru Yoshida, Takeshi Kimura, Tsutomu Chiba, Eiichiro Nishi, Hiroshi Seno
Keitaro Kanda, Jiro Sakamoto, Yoshihide Matsumoto, Kozo Ikuta, Norihiro Goto, Yusuke Morita, Mikiko Ohno, Kiyoto Nishi, Koji Eto, Yuto Kimura, Yuki Nakanishi, Kanako Ikegami, Takaaki Yoshikawa, Akihisa Fukuda, Kenji Kawada, Yoshiharu Sakai, Akihiro Ito, Minoru Yoshida, Takeshi Kimura, Tsutomu Chiba, Eiichiro Nishi, Hiroshi Seno
View: Text | PDF
Research Article Oncology

Nardilysin controls intestinal tumorigenesis through HDAC1/p53–dependent transcriptional regulation

  • Text
  • PDF
Abstract

Colon cancer is a complex disease affected by a combination of genetic and epigenetic factors. Here we demonstrate that nardilysin (N-arginine dibasic convertase; NRDC), a metalloendopeptidase of the M16 family, regulates intestinal tumorigenesis via its nuclear functions. NRDC is highly expressed in human colorectal cancers. Deletion of the Nrdc gene in ApcMin mice crucially suppressed intestinal tumor development. In ApcMin mice, epithelial cell–specific deletion of Nrdc recapitulated the tumor suppression observed in Nrdc-null mice. Moreover, epithelial cell–specific overexpression of Nrdc significantly enhanced tumor formation in ApcMin mice. Notably, epithelial NRDC controlled cell apoptosis in a gene dosage–dependent manner. In human colon cancer cells, nuclear NRDC directly associated with HDAC1, and controlled both acetylation and stabilization of p53, with alterations of p53 target apoptotic factors. These findings demonstrate that NRDC is critically involved in intestinal tumorigenesis through its epigenetic regulatory function, and targeting NRDC may lead to a novel prevention or therapeutic strategy against colon cancer.

Authors

Keitaro Kanda, Jiro Sakamoto, Yoshihide Matsumoto, Kozo Ikuta, Norihiro Goto, Yusuke Morita, Mikiko Ohno, Kiyoto Nishi, Koji Eto, Yuto Kimura, Yuki Nakanishi, Kanako Ikegami, Takaaki Yoshikawa, Akihisa Fukuda, Kenji Kawada, Yoshiharu Sakai, Akihiro Ito, Minoru Yoshida, Takeshi Kimura, Tsutomu Chiba, Eiichiro Nishi, Hiroshi Seno

×

Figure 3

Forced expression of NRDC in epithelial cells enhances ApcMin mouse intestinal tumors.

Options: View larger image (or click on image) Download as PowerPoint
Forced expression of NRDC in epithelial cells enhances ApcMin mouse inte...
(A) Representative H&E staining of the small intestines of ApcMin and ApcMin; Villin-Nrdc (V-Nrdc) mice. (B) ApcMin; Villin-Nrdc mice showed a greater increase in tumor formation in the small intestine (SI) than ApcMin mice (n = 6–11). *P < 0.05 by unpaired 2-tailed Student’s t test. Total number (left) and number in each size fraction (right) are depicted. (C) Representative H&E staining of colon tumors (dotted area) in ApcMin and ApcMin; Villin-Nrdc mice. (D) The numbers of colon tumors in ApcMin and ApcMin; Villin-Nrdc mice (n = 11). *P < 0.05 by unpaired 2-tailed Student’s t test. (E) A Kaplan-Meier analysis demonstrated that ApcMin; Villin-Nrdc mice showed a significantly shorter survival compared with ApcMin mice (n = 11). *P < 0.001 by log-rank test. (F) Immunostaining for Ki67 in ApcMin and ApcMin; Villin-Nrdc mice. (G) There was no difference in Ki67-positive cells between ApcMin and ApcMin; Villin-Nrdc mice (n = 7). (H) Immunostaining for cleaved caspase-3 in ApcMin and ApcMin; Villin-Nrdc mice. (I) The percentage of cleaved caspase-3–positive apoptotic cells was decreased in ApcMin; Villin-Nrdc mice (n = 7). *P < 0.05 by unpaired 2-tailed Student’s t test. All scale bars: 100 μm.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts